April 25, 2018 12:59 PM ET


Company Overview of Sangart, Inc.

Company Overview

Sangart, Inc., a biopharmaceutical company, researches, develops, and commercializes oxygen therapeutics. It offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation. The company’s MP4CO, a biopharmaceutical product is used for the treatment of acute painful sickling crises in patients with sickle cell disease. Sangart, Inc. was founded in 1998 and is based in San Diego, California.

6175 Lusk Boulevard

San Diego, CA 92121

United States

Founded in 1998





Key Executives for Sangart, Inc.

Chief Operating Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sangart, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.